- Home
- CRWD vs GSK Comparison
CRWD vs GSK Comparison
Compare CRWD & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRWD | GSK |
|---|---|---|
| Founded | 2011 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | 66841 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.7B | 108.7B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRWD | GSK |
|---|---|---|
| Price | $595.60 | $49.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 48 | 2 |
| Target Price | ★ $507.00 | N/A |
| AVG Volume (30 Days) | 2.5M | ★ 4.0M |
| Earning Date | 06-02-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,812,005,000.00 | N/A |
| Revenue This Year | $24.85 | $6.99 |
| Revenue Next Year | $21.40 | $4.19 |
| P/E Ratio | ★ N/A | $32.75 |
| Revenue Growth | ★ 21.71 | N/A |
| 52 Week Low | $342.72 | $35.45 |
| 52 Week High | $583.78 | $61.70 |
Technical Indicators
Market Signals| Indicator | CRWD | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 82.59 | 31.92 |
| Support Level | $477.12 | $47.89 |
| Resistance Level | N/A | $51.46 |
| Average True Range (ATR) | 21.13 | 0.87 |
| MACD | 11.97 | -0.14 |
| Stochastic Oscillator | 98.83 | 3.73 |
Price Performance
Historical ComparisonAbout CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.